Literature DB >> 11696288

Causes and treatment of functional dyspepsia.

J Tack1, R Bisschops, B DeMarchi.   

Abstract

Functional dyspepsia is a clinical syndrome defined by upper abdominal symptoms without identifiable cause by conventional diagnostic means. Recent studies have established that functional dyspepsia is a heterogeneous disorder in which different pathophysiologic disturbances underlie different symptom profiles. Delayed gastric emptying is associated with postprandial fullness, nausea, and vomiting; impaired accommodation is associated with early satiety and weight loss; and hypersensitivity to gastric distention is associated with epigastric pain, belching, and weight loss. The pathogenesis of functional dyspepsia is unknown but may be postinfectious in a subgroup of patients. The role of psychological disturbances and of duodenal hypersensitivity requires further study. Treatment of the underlying pathophysiologic abnormality seems logical, but options for pharmacotherapy are limited to acid suppression, prokinetic drugs, and antidepressants. Psychotherapy can be considered for refractory patients. Several novel drug therapies are under evaluation.

Entities:  

Mesh:

Year:  2001        PMID: 11696288     DOI: 10.1007/s11894-001-0071-y

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  44 in total

1.  Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients.

Authors:  L E Troncon; R J Bennett; N K Ahluwalia; D G Thompson
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

2.  Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia.

Authors:  J Tack; P Caenepeel; B Fischler; H Piessevaux; J Janssens
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

3.  Perception of changes in wall tension of the proximal stomach in humans.

Authors:  H Piessevaux; J Tack; A Wilmer; B Coulie; A Geubel; J Janssens
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

Review 4.  Systematic review of the epidemiological evidence on Helicobacter pylori infection and nonulcer or uninvestigated dyspepsia.

Authors:  J Danesh; M Lawrence; M Murphy; S Roberts; R Collins
Journal:  Arch Intern Med       Date:  2000-04-24

5.  A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin.

Authors:  L Tanum; U F Malt
Journal:  Scand J Gastroenterol       Date:  1996-04       Impact factor: 2.423

6.  Effect of the kappa agonist fedotozine on perception of gastric distension in healthy humans.

Authors:  B Coffin; D Bouhassira; R Chollet; B Fraitag; C De Meynard; J Geneve; M Lemann; J C Willer; R Jian
Journal:  Aliment Pharmacol Ther       Date:  1996-12       Impact factor: 8.171

7.  Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia.

Authors:  C Feinle; O Meier; B Otto; M D'Amato; M Fried
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

8.  Excess sick-listing in nonulcer dyspepsia.

Authors:  O Nyrén; H O Adami; S Gustavsson; L Lööf
Journal:  J Clin Gastroenterol       Date:  1986-06       Impact factor: 3.062

9.  Psychometric scores and persistence of irritable bowel after infectious diarrhoea.

Authors:  K A Gwee; J C Graham; M W McKendrick; S M Collins; J S Marshall; S J Walters; N W Read
Journal:  Lancet       Date:  1996-01-20       Impact factor: 79.321

10.  Discriminant analysis of factors distinguishing patients with functional dyspepsia from patients with duodenal ulcer. Significance of somatization.

Authors:  I Wilhelmsen; T T Haug; H Ursin; A Berstad
Journal:  Dig Dis Sci       Date:  1995-05       Impact factor: 3.199

View more
  8 in total

1.  Treatment of Functional GI Disorders With Psychotropic Medicines: A Review of Evidence With a Practical Approach.

Authors:  Syed I M Thiwan; Douglas A Drossman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-09

Review 2.  Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification.

Authors:  Hidekazu Suzuki; Toshihiro Nishizawa; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2006-06       Impact factor: 7.527

3.  Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying.

Authors:  J Arts; P Caenepeel; K Verbeke; J Tack
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

4.  Treatment of Functional Dyspepsia.

Authors:  Christine Feinle-Bisset; Jane M. Andrews
Journal:  Curr Treat Options Gastroenterol       Date:  2003-08

5.  Effects of tegaserod and erythromycin in upper gut dysmotility: a comparative study.

Authors:  Issam Nasr; Satish S C Rao; Ashok Attaluri; Syed M A Hashmi; Robert Summers
Journal:  Indian J Gastroenterol       Date:  2009-11-24

Review 6.  Serotonin pharmacology in the gastrointestinal tract: a review.

Authors:  D T Beattie; J A M Smith
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-09       Impact factor: 3.000

7.  Effect of DA-9701 on Gastric Motor Function Assessed by Magnetic Resonance Imaging in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Yang Won Min; Byung-Hoon Min; Seonwoo Kim; Dongil Choi; Poong-Lyul Rhee
Journal:  PLoS One       Date:  2015-09-24       Impact factor: 3.240

Review 8.  Dietary fat intake and functional dyspepsia.

Authors:  Mahdieh Khodarahmi; Leila Azadbakht
Journal:  Adv Biomed Res       Date:  2016-04-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.